Active	Status	Sponsor type	Region	Phase	Filter
5 Active 5 Inactive 10 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wang, Xiaoping
NCT05058040: A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules (GV-971)	Active, not recruiting	4	2500	RoW	Sodium Oligomannate Capsules	Green Valley (Shanghai) Pharmaceuticals Co., Ltd.	Alzheimer Disease	01/25	04/25
NCT04693351 / 2020-004653-69: Efficacy and Safety Study of Adjunctive Troriluzule in Obsessive Compulsive Disorder	Active, not recruiting	3	700	Europe, Canada, US, RoW	Troriluzole, Placebo	Biohaven Pharmaceuticals, Inc.	Obsessive-Compulsive Disorder	04/25	04/25
SCDB, NCT06422845: Peripheral Scoring Drug-coated Balloon in the Treatment of Hemodialysis Arteriovenous Fistula Stenosis	Recruiting	N/A	328	RoW	Dissolve AV Peripheral Scoring Drug-coated Balloon, Scoring Drug-coated Balloon	DK Medical Technology (Suzhou) Co., Ltd.	Arteriovenous Fistula Stenosis	07/27	07/27
Zhou, Bing
NCT04381143: ASPIrin in Reducing Events in Dialysis ( ASPIRED )	Recruiting	4	9000	RoW	Aspirin 100 mg Oral Tablet, Matching Placebo	Guangdong Provincial People's Hospital, The George Institute	CKD (Chronic Kidney Disease) Stage 5D	09/26	12/26
Ma, Yifeng
NCT04381143: ASPIrin in Reducing Events in Dialysis ( ASPIRED )	Recruiting	4	9000	RoW	Aspirin 100 mg Oral Tablet, Matching Placebo	Guangdong Provincial People's Hospital, The George Institute	CKD (Chronic Kidney Disease) Stage 5D	09/26	12/26